Variable | Blend 1 (mean ± SD) | Blend 2 (mean ± SD) | Placebo (mean ± SD) |
---|---|---|---|
Endothelial Function | Â | Â | Â |
Flow-mediated dilatation, % | 0.60 ± 4.30 | 1.00 ± 3.401 | 0.60 ± 4.20 |
Stimulus-adjusted response measure | -0.04 ± 0.33 | -0.04 ± 0.28 | -0.05 ± 0.28 |
Serum Measures | Â | Â | Â |
Insulin, pmol/L | 65.28 ± 362.53 | -29.17 ± 232.66 | 20.14 ± 225.71 |
Fasting plasma glucose, mmol/L | 0.16 ± 1.75 | 0.11 ± 1.69 | 0.07 ± 1.61 |
Anthropometric Measures | Â | Â | Â |
Body Weight, kg | 0.90 ± 2.90 | 0.20 ± 2.50 | 0.40 ± 2.00 |
Body Mass Index, kg/m2 | 0.30 ± 0.90 | 0.00 ± 0.80 | 0.10 ± 0.70 |
Lipid Panel | Â | Â | Â |
Total Cholesterol, mmol/L | 0.10 ± 0.62 | 0.04 ± 0.49 | 0.01 ± 0.62 |
High Density Lipoprotein (HDL), mmol/L | 0.04 ± 0.21 | 0.06 ± 0.15 | 0.10 ± 0.17 |
Total Cholesterol/HDL | -0.10 ± 0.70 | 0.00 ± 0.801 | -0.40 ± 0.80 |
Triglycerides, mmol/L | 0.03 ± 0.71 | 0.24 ± 0.60 | -0.19 ± 0.87 |
Low Density Lipoprotein (LDL), mmol/L | -0.04 ± 0.71 | 0.11 ± 0.55 | -0.01 ± 0.74 |